drugset / Trial / NCT05642793
Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
This is an unmasking randomized clinical trial. the main purpose of this study is to analyze whether posvitrectomy proactive use of conbercept can reduce the rate of postoperative complication in PDR patients.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2023-09-30
- Completion
- 2024-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conbercept | Protein / enzyme biologic | — | Intravitreal |